| Citation: | ZHAN Shumin, HUANG Ke, WU Wei, GU Weizhong, FU Junfen, DONG Guanping. Primary aldosteronism in young child: a case report and literature review[J]. Chinese Journal of General Practice, 2024, 22(4): 717-720. doi: 10.16766/j.cnki.issn.1674-4152.003487
|
| [1] |
XU Z, YANG J, HU J, et al. Primary aldosteronism in patients in China with recently detected hypertension[J]. J Am Coll Cardiol, 2020, 75(16): 1913-1922. doi: 10.1016/j.jacc.2020.02.052
|
| [2] |
SHI X, MA D, LI M, et al. A de novo mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset hypertension[J]. J HYPERTENS, 2019, 37(8): 1731-1733. doi: 10.1097/HJH.0000000000002138
|
| [3] |
王慧萍, 文进, 崔云英, 等. 一例儿童醛固酮和皮质醇共分泌肾上腺瘤的临床表现及全外显子测序分析[J]. 基础医学与临床, 2021, 41(3): 352-357. doi: 10.3969/j.issn.1001-6325.2021.03.007
WANG H P, WEN J, CUI Y Y, et al. Whole-exome sequencing from a case of pediatric aldosterone-and cortisol-coproducing adrenal adenoma[J]. Basic & Clinical Medicine, 2021, 41(3): 352-357. doi: 10.3969/j.issn.1001-6325.2021.03.007
|
| [4] |
王超超, 林永强, 赵润英, 等. 螺内酯对腹膜透析患者心脏及残余肾功能的影响[J]. 中华全科医学, 2018, 16(8): 1303-1307. doi: 10.16766/j.cnki.issn.1674-4152.000358
WANG C C, LIN Y Q, ZHAO R Y, et al. Effects of spironolactone on cardiac and residual renal function in patients with peritoneal dialysis[J]. Chinese Journal of General Practice, 2018, 16(8): 1303-1307. doi: 10.16766/j.cnki.issn.1674-4152.000358
|
| [5] |
RIGGS E R, ANDERSEN E F, CHERRY A M, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2020, 22(2): 245-257. doi: 10.1038/s41436-019-0686-8
|
| [6] |
中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36(9): 727-736. doi: 10.3760/cma.j.cn311282-20200615-00444
Chinese Society of Endocrinology. Expert consensus on the diagnosis and treatment of primary aldosteronism (2020)[J]. Chinese Journal of Endocrinology and Metabolism, 2020, 36(9): 727-736. doi: 10.3760/cma.j.cn311282-20200615-00444
|
| [7] |
SONG Y, YANG S, HE W, et al. Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study[J]. Hypertension, 2018, 71(1): 118-124. doi: 10.1161/HYPERTENSIONAHA.117.10197
|
| [8] |
KIETSIRIROJE N, WONGHIRUNDECHA R, SUNTORNLOHANAKUL O, et al. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism[J]. Clin Endocrinol (Oxf), 2020, 92(3): 196-205. doi: 10.1111/cen.14142
|
| [9] |
WANG M H, LI N F, LUO Q, et al. Development and validation of a novel diagnostic nomogram model to predict primary aldosteronism in patients with hypertension[J]. Endocrine, 2021, 73(3): 682-692. doi: 10.1007/s12020-021-02745-7
|
| [10] |
王来丽, 宋洪斌, 周锋. 肾素-血管紧张素-醛固酮系统检测在醛固酮腺瘤中的诊断价值[J]. 现代医药卫生, 2023, 39(2): 250-253. https://www.cnki.com.cn/Article/CJFDTOTAL-XYWS202302015.htm
WANG L L, SONG H B, ZHOU F. Diagnostic value of renin-angiotensin-aldosterone system in aldosterone adenoma[J]. Journal of Modern Medicine & Health, 2023, 39(2): 250-253. https://www.cnki.com.cn/Article/CJFDTOTAL-XYWS202302015.htm
|
| [11] |
LIU X, JIN L, ZHANG H, et al. A Chinese pedigree with glucocorticoid remediable aldosteronism[J]. Hypertens Res, 2021, 44(11): 1428-1433. doi: 10.1038/s41440-021-00685-3
|
| [12] |
MARIA A G, SUZUKI M, BERTHON A, et al. Mosaicism for KCNJ5 causing early-onset primary aldosteronism due to bilateral adrenocortical hyperplasia[J]. Am J Hypertens, 2020, 33(2): 124-130. doi: 10.1093/ajh/hpz172
|
| [13] |
BOULKROUN S, FERNANDES-ROSA F L, ZENNARO M C. Old and new genes in primary aldosteronism[J]. Best Pract Res Clin Endocrinol Metab, 2020, 34(2): 101375. DOI: 10.1016/j.beem.2020.101375.
|
| [14] |
SCHOLL U I, STÖLTING G, NELSON-WILLIAMS C, et al. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism[J]. Elife, 2015, 24(4): e06315. DOI: 10.7554/eLife.06315.
|
| [15] |
SCHOLL U I, STÖLTING G, SCHEWE J, et al. CLCN2 chloride channel mutations in familial hyperaldosteronism type Ⅱ[J]. Nat Genet, 2018, 50(3): 349-354. doi: 10.1038/s41588-018-0048-5
|
| [16] |
FERNANDES-ROSA F L, DANⅡL G, OROZCO I J, et al. A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism[J]. Nat Genet, 2018, 50(3): 355-361. doi: 10.1038/s41588-018-0053-8
|
Figures(3)
Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com
Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2
Supported by:
Beijing Renhe Information Technology Co., Ltd.
DownLoad:
